U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07058688) titled 'A Study of NTRX-07 in Participants With Alzheimer's Disease' on April 15.
Brief Summary: 1. Study Overview NeuroTherapia Inc. is conducting a clinical study to explore the safety and effects of a new drug called NTRX- 07. This drug targets people with mild cognitive impairment (MCI) or mild to moderate Alzheimer's disease (AD). The study's primary focus is on safety and how the drug interacts with the body over a short-term period of 28 days. This research is important as it aims to find new ways to manage symptoms and slow the progression of AD.
2. Key Objectives Primary Objective:
* To assess the safety and tolerability of NTRX-...